Patent · US Active

Induction of hemogenic endothelium from pluripotent stem cells by forced expression of transcription factors

US10106771B2 · kind B2 · utility

0Cited by
9References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 23, 2017
Grant dateOct 23, 2018
Priority date
Expiry dateAug 23, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16043
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Described herein are methods and related compositions for inducing differentiation of human pluripotent stem cells (hPSCs) into hemogenic endothelium with pan-myeloid potential or restricted potential, by forced expression in the hPSCs of a combination of transcription factors as described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.